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Abstract: Introduction: Despite the availability of guidelines for the evaluation of candidates for
renal transplantation, variation in access to transplantation exists. This national survey
investigates whether centre variation exists in the assessment of patients for renal
transplantation in the UK.
Methods: An online survey, informed by qualitative interviews, was distributed to all UK
renal centres. This survey examined centre approaches to chronic kidney disease
service provision, transplant recipient assessment, education provision and wait-listing
decision making processes. Centre re-evaluation policies for patients already listed
and priorities for future development were also examined.
Results: All 71 renal centres responded. Of these, 83% reviewed pre-dialysis patients
in a low clearance clinic. In 26% of centres transplantation was not discussed as a
treatment option with all patients. Fourteen centres reported having a dedicated
transplant assessment clinic whilst 28% did not have a formal assessment protocol.
Age was an exclusion criterion for listing in three centres, all of which had a cut off at
75 years. 83% of centres excluded patients with a high BMI. Cardiac investigations
were risk-stratified in 90% of centres. Surgical involvement varied with 11% of centres
listing patients without formal surgical review. There was no formal protocol in place to
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
re-evaluate listed patients in 62% of centres.
Conclusions: There is wide variation in UK practice patterns for listing patients for renal
transplantation, though its impact on access to transplantation is unclear. The extent to
which centre-specific and patient-specific factors affect access to transplantation
requires further analysis in a prospective cohort of patients.
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Abstract 
Introduction: Despite the availability of guidelines for the evaluation of candidates 
for renal transplantation, variation in access to transplantation exists. This national 
survey investigates whether centre variation exists in the assessment of patients for 
renal transplantation in the UK. 
Methods: An online survey, informed by qualitative interviews, was distributed to all 
UK renal centres. This survey examined centre approaches to chronic kidney 
disease service provision, transplant recipient assessment, education provision and 
wait-listing decision making processes. Centre re-evaluation policies for patients 
already listed and priorities for future development were also examined. 
Results: All 71 renal centres responded. Of these, 83% reviewed pre-dialysis 
patients in a low clearance clinic. In 26% of centres transplantation was not 
discussed as a treatment option with all patients. Fourteen centres reported having a 
dedicated transplant assessment clinic whilst 28% did not have a formal assessment 
protocol. Age was an exclusion criterion for listing in three centres, all of which had a 
cut off at 75 years. 83% of centres excluded patients with a high BMI. Cardiac 
investigations were risk-stratified in 90% of centres. Surgical involvement varied with 
11% of centres listing patients without formal surgical review. There was no formal 
protocol in place to re-evaluate listed patients in 62% of centres. 
Conclusions: There is wide variation in UK practice patterns for listing patients for 
renal transplantation, though its impact on access to transplantation is unclear. The 
extent to which centre-specific and patient-specific factors affect access to 
transplantation requires further analysis in a prospective cohort of patients. 
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Introduction 
It is widely regarded that for ‘suitable’ patients with end stage renal failure (ESRF), 
renal transplantation confers both better quality of life and life expectancy than 
dialysis and is the preferred modality of renal replacement therapy (RRT)1-4. In light 
of these benefits, achieving prompt and timely activation on the transplant waiting list 
is important not least because increasing length of time on dialysis adversely affects 
graft and patient survival5, but also because organ allocation algorithms in many 
countries (including the UK) give priority to those who have spent greater time on the 
waiting list when allocating deceased donor kidneys6-7. Thus, centres that achieve 
earlier listing for transplantation may provide an advantage for their patients 
compared with centres that take longer.  
Various guidelines on the timing of referral for renal transplantation are available 
from professional organisations across the world8-10. Guidelines from the United 
States Organ Procurement and Transplantation Network (OPTN) Minority Affairs 
Committee state that the goal for referral should be that all potential candidates are 
referred for transplant at an estimated glomerular filtration rate (eGFR) above 20 
ml/min/1.73m2 to favour early transplantation and avoid the development of 
comorbidities associated with dialysis as well as allowing patients to accrue waiting 
time that increases their chance of being allocated a donor organ8. In comparison 
the UK Renal Association guidelines recommend that patients with progressive 
deterioration in renal function suitable for transplantation should be placed on the 
national transplant list within six months of their anticipated dialysis start date and 
that pre-emptive transplantation should be the treatment of choice for all suitable 
patients whenever a living donor is available10. 
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The term ‘suitable’ used in these guidelines often poses a conundrum for clinicians 
as objective criteria to confirm suitability for transplantation are not clearly defined 
and hence are open to interpretation. To assist this process guidelines for the 
evaluation of candidates for renal transplantation have been published by the 
American Society of Transplantation11, the European Renal Association and 
European Society for Organ Transplantation12, the UK Renal Association10, the 
British Transplantation Society13 and Caring for Australasians with Renal 
Impairment14. Despite the availability of clinical guidelines, significant variations in 
the assessment practices among transplant centres have been reported in the 
United States as well as Europe15-17.  
To explore this further we undertook a national survey as part of the NIHR funded 
Access to Transplantation and Transplant Outcome Measures (ATTOM) programme 
to examine whether variation exists in the organisation of renal services in listing 
patients, and to describe centre practices in the education and the evaluation of 
potential transplant recipients as well as exploring how decisions are made in the 
UK. 
Materials and Methods 
A structured online and paper-based survey consisting of 96 questions was 
developed using the results of two qualitative studies carried out within the ATTOM 
programme18,19. Qualitative studies included 53 patients and 42 healthcare 
professionals, and explored patients’ views and experiences of joining the transplant 
waiting list and staff members’ experiences of listing patients for transplantation. 
Staff and patients were recruited from a purposive maximum variation sample of nine 
renal units in the UK. Existing published literature was also reviewed and feedback 
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 7 
sought and incorporated from a group of experts on the ATTOM steering group. Pilot 
face-to-face interviews with 4 clinicians were conducted using the first draft survey to 
guide revision to improve instrument face and content validity and usability prior to 
distribution.  
The questionnaire was designed to establish the practice patterns of the unit relating 
to listing patients aged <75 years for transplantation. Once finalised, both versions 
(online and paper-based) of the survey were sent to the lead physicians and 
surgeons of all 71 adult renal centres in the UK in January 2014. Clinicians were 
invited either to complete the survey personally or to nominate a representative 
within the unit to respond. It was specified that the respondent's answers should 
reflect current practice in the unit rather than individual preference.  
Statistical analyses were performed using SAS version 9.3. Results for each 
question were expressed as a percentage of the total number of centres responding 
to the question. We identified several factors a priori as ‘exposure’ variables and 
tested for associations of these categorical variables with care processes using Chi 
squared test or Mann Whitney test. Given the potential for multiple testing and false 
positives we only report associations that were significant at p<0.01. In order to 
measure how much time renal staff were involved in transplantation listing, Whole-
time equivalent (WTE) time was asked. An WTE of 1.0 indicates that a person is 
equivalent to a Whole-time worker, or 2 persons working half-time.   
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Results 
A completed survey was received from all 71 (100%) adult centres in the UK, of 
which 23 were transplanting and 48 were non-transplanting renal centres. The 
reported roles of respondents were: Clinical Director (42.3%), Consultant 
Nephrologist (49.3%), Consultant Transplant Surgeon (2.8%) and ‘Other health 
professional’ (5.6%). Forty centres (56.3%) completed the web-based version and 31 
centres (43.7%) the paper version of the survey. The responding centres had a total 
of 6699 patients active on the UK transplant waiting list at the end of 2012 and 
reported a national workforce involved in listing patients for transplantation which 
comprised of 488 WTE Consultant Nephrologists, 113 WTE Transplant Surgeons, 57 
WTE Associate Specialists, 73 WTE Transplant Co-ordinators and 75 WTE Live 
Kidney Donor Nurses. The median number of Consultant Nephrologists was 
significantly greater at transplanting centres (8.5; IQR 8-11) compared with non-
transplanting centres (4.5; IQR 3-6), p<0.001).  
 
Chronic Kidney Disease Workforce and Organisation 
Almost 48% (47.9%, n=34) of centres reported seeing all pre-dialysis patients in a 
dedicated low-clearance clinic (LCC), whilst 33.8% (n=24) of centres used a LCC for 
some of their patients. The remaining 18.3% (n=13) of centres did not have a 
designated LCC service. There was no significant difference between non-
transplanting and transplanting centres in terms of the pattern of LCC utilisation.  
LCCs were mostly joint (consultant with nurse, 48.3%) or consultant-led (43.1%), 
with only 8.6% of centres having a nurse-led service. When LCCs were present, 
30% of non-transplanting centres did not have a specified protocol for referral for 
transplantation compared with 11.1% of transplanting centres (p<0.001). 
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Transplantation Education 
Transplantation was discussed as a treatment option with all patients under the age 
of 75 in 51 (71.8%) of centres, with other centres reporting a more selective policy. 
The decision not to discuss was made mostly by a consultant led multi-disciplinary 
team (MDT) (55%) or solely by a consultant nephrologist (40%). Discussions 
regarding transplantation were led most often by a consultant nephrologist (64.8%), 
with nurses leading the discussion in 19.7%, transplant surgeons in 2.8% and ‘other’ 
healthcare professionals in 12.6% of centres. Despite reporting a wide range of 
educational delivery tools, education almost always took the form of a one-to-one 
consultation (98.6%) where patients were given literature to take home to read 
(91.5%).  
 
Transplant Listing Pathway and Role of Transplant Surgeons 
The clinical setting for transplant assessment varied, with 36.4% of centres utilising a 
LCC, 21.2% seeing patients in their usual CKD clinic and 19.7% utilising a specific 
transplant assessment clinic. The remaining 22.7% of centres reported a mix of 
‘other’ clinical settings. The use of specific transplant assessment clinics was similar 
in non-transplanting centres and transplanting centres, though the frequency varied 
widely, with clinics occurring monthly or less frequently in 55% of non-transplanting 
centres, as compared with 100% of transplanting centres running these clinics 
fortnightly or more frequently, p<0.001. Overall 88.2% (n=63) of centres required all 
patients to be seen by a Transplant Surgeon prior to being listed; of the remaining 8 
centres that did not require direct surgical review, 4 centres (1 transplanting and 3 
non-transplanting) reported that all patients were discussed with a Transplant 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 10 
Surgeon, whilst 4 centres reported no surgical involvement in the decision to list for 
transplantation. 
 
The Assessment Process 
Nationally 30% (n=21) of centres did not have a written transplant work-up protocol 
for recipient assessment, which included 3 transplant centres. Figure 1 shows the 
frequency with which different investigations were used for the routine assessment of 
potential renal transplant recipients amongst the 71 centres. Three non-transplanting 
centres reported having an upper age limit of 75 years (above which patients were 
only considered in exceptional circumstances for transplantation) whilst all other 
centres (n=68, 95.6%) did not report any age restrictions. In comparison, Body Mass 
Index (BMI) was widely used as an exclusion criterion for listing patients, with 81.7% 
(n=58) of centres excluding patients for transplantation based on BMI. The overall 
median upper BMI cut off, in these centres was 35 (IQR: 33.25-35), with 36 centres 
reporting an upper limit of 35, and 5 centres an upper limit of 40 whilst the remaining 
17 centres stated a BMI limit between 33-30. The reasons stated for using BMI as an 
exclusion criterion are summarised in Table 1. These did not differ between centres 
other than perceived increased cardiovascular risk, which appeared to be more of an 
issue for non-transplanting (52.5%) than transplanting centres (33.3%), p<0.01. 
All transplanting centres, and 87.5% (n=65) of non-transplanting centres reported 
stratifying patients by risk when deciding which cardiac investigations to perform. 
Age (median 50 years; IQR: 50-55)(88%), diabetes (97%), previous cardiovascular 
disease (91%), and an abnormal ECG (89%) were used to determine risk. Thirty-one 
centres (44%) conducted some form of ‘cardiac stress testing’ even in low risk 
patients whilst significant variation was seen in the first-line investigation of choice 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 11 
for the assessment of coronary artery disease in high risk patients (Table 2). If a 
coronary angiogram was deemed necessary for listing a low clearance patient, 5.6% 
(n=4) of centres reported they would refrain from performing the test until patients 
were on dialysis to avoid precipitating the need for dialysis, with a further 74.6% 
stating they would ‘sometimes’ refrain from proceeding. Only 19.7% reported always 
proceeding.  
Variation was also seen in screening for malignancies with 38% of centres reporting 
that screening for cancer such as breast, prostate, bladder and colorectal was part of 
the routine work-up of transplant recipients, in addition to national screening 
programmes. In contrast, formal psychological or cognitive assessment of all 
potential recipients was only performed in 7.0% and 5.6% of centres respectively, 
with 13.1% of centres reporting no access to psychologist or counsellor services. 
 
Decision Making  
Overall 76.1% (n=54) of centres utilised an MDT approach when listing patients for 
transplantation. This proportion was greater amongst transplanting centres where all 
but one centre (95.7%) used an MDT, compared to 66.7% (n=54) in non-
transplanting centres. MDTs occurred more frequently in transplanting centres with a 
median of 4 meetings a month (IQR 1.25-4) as compared to 2 a month (IQR 1-4;p= 
0.001) in non-transplanting centres.   
If a patient was not deemed suitable for listing for deceased donor transplantation, 
76.1% of centres said that they would consider listing them for living donor 
transplantation if a suitable donor was available. Living donor availability was 
generally seen as a positive driver for listing, alongside patient enthusiasm, whilst 
the majority of centres did not perceive socioeconomic factors, including employment 
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status or level of patient education, as important when deciding whether to list 
patients for transplantation (Figure 2).  Once a decision regarding listing was made, 
50.7% of centres reported informing all patients on dialysis, or with CKD stage 5 
under 75 years, of the decision, with 78.6% of centres recording all decisions made 
on transplant suitability on their electronic patient record (EPR). Once recorded on 
their EPR, only 61.8% of centres performed regular audit of this information.  
After listing, only 38% of centres reported having a protocol in place to monitor 
patients activated on the transplant list with the majority of centres (53.5%) reviewing 
patient suitability annually. Significant variation existed in how centres undertook on-
going surveillance for cardiac disease in asymptomatic patients once listed as shown 
(Table 3). This was also highlighted in centres’ responses to questions on improving 
listing, with 53 centres (74.6%) either agreeing or strongly agreeing with the need for 
having a national consensus on cardiac work up, and 52 centres (73.2%) also 
agreeing that there was a need for a consensus on the entire assessment work-up 
process (Figure 3). 
 
Inter-Centre Relationships and Future Development 
Although 95% of centres reported having a positive relationship with a ‘good’, ‘very 
good’ or ‘excellent’ relationship with their associated transplanting/non-transplanting 
centres, one third (n=16) of non-transplanting centres felt that accessing an 
appointment at their affiliated transplanting centre was a significant source of delay 
in listing patients. 
Factors reported by centres to be most important in improving listing of patients for 
transplantation included: providing a better evidence base behind necessary 
assessment work up; improving the commissioning of transplant work up by funders 
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of the service; and developing a national consensus on the work up of transplant 
recipients (Figure 3). If extra funding was available, centres stated they would use 
this to increase the number of transplant co-ordinators and living-donor nurses, 
increasing the number of operation time slots for transplantation in trusts, and 
providing administrative support for allied health professionals involved in 
transplantation would likely improve overall listing and time to listing in their centres 
(Figure 4). 
Discussion  
This study provides the most extensive exploration to date of clinical practice 
patterns within renal centres in listing patients for renal transplantation in the UK; and 
is the first to account for practice patterns in both transplanting and non-transplanting 
centres. It provides a comprehensive overview of the transplant-listing pathway 
including staffing levels, clinic arrangements, provision of patient education on 
transplantation, decision-making, recipient assessment, surgical review, criteria for 
listing, and the role of MDTs. 
For a national population of 64.1 million20 the number of consultant transplant 
surgeons reported (1.76 per million population) (pmp) in this survey remains 
significantly lower than the 2pmp recommended by the Royal College of Surgeons of 
England21. Indeed the number of consultant nephrologists (7.61pmp), transplant co-
ordinators (1.14pmp) and living-donor nurses (1.17pmp) are all significantly lower 
than that recommended by the National Renal Workforce Planning Group and point 
towards an understaffed service21.  
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Despite the UK Renal Association recommending that CKD patients pre RRT should 
be managed in a dedicated clinic by a MDT22, this study also demonstrated wide 
variation in the utilisation of low-clearance clinics nationally, with variation also seen 
in their implementation and entry criteria. There are many studies, albeit small, which 
have shown that a dedicated pre- dialysis clinic is associated with improved 
outcomes and reduced urgent initiation of dialysis23-26. These clinics may provide 
focused opportunity to assess transplantation potential and more timely discussion of 
options including live donation and pre-emptive transplantation. Similarly, specific 
transplant-assessment clinics (used by a fifth of centres) enable joint assessment by 
physician and surgeon; whilst the evidence of their effectiveness is lacking they may 
be more efficient at transplant listing.  
Irrespective of the type of CKD service in place, a broad range of educational 
methods were utilised across the UK, with one-to-one education being the main 
route.  A significant proportion of centres (28%) did not discuss transplantation as a 
treatment option with all patients under the age of 75 years, and nearly 50% of 
patients who had had a decision made about them regarding transplantation were 
not informed of the decision made. This is of concern, as a patient-centred approach 
would require that all options are communicated to a patient and their family where 
possible. There may be exceptional circumstances where this may not always be 
feasible, but such instances would be expected to be less frequent than was 
reported in the present study. 
Another important observation from this study was that some centres did not 
consider surgical review to be an absolute requirement for listing patients for 
transplantation. Eight centres listed without formal review, four of which cited no 
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surgical involvement at all. The UK Renal Transplant Service specification stipulates 
that patients should undergo surgical assessment prior to being placed on the 
transplant list27, however it should be noted that in the US it is not uncommon to 
have only a subset of patients evaluated by transplant surgery in a face-to-face 
encounter. Instead, they selectively evaluate higher risk patients, e.g., those with 
vascular disease. 
Whilst in these centres it might be perceived that informed consent need not be 
taken by a surgeon and can instead be obtained by an experienced physician. The 
authors question whether without surgical input, patients can truly make an 
adequately informed choice and be involved in shared decision-making about 
transplantation and the associated surgical risks. Chronic understaffing described 
earlier and the belief that surgical evaluation of every patient prior to listing 
might reduce/delay access to transplant, may partly explain why centres have 
adopted such practices, though its impact on outcome is not known.  
Several national guidelines recommend that centres should have written criteria for 
acceptance of patients onto the waiting list10, 28, yet nearly a third of centres reported 
not having a protocol, including three transplanting centres. The lack of 
standardisation in these units could lead to variation in assessment, stereotyping, 
individual clinician bias and personal idiosyncrasies contributing to inequity. It was 
reassuring that the majority of centres (95.6%) did not use chronological age per se 
as an exclusion criterion. This figure is higher than that seen in the US, where 66% 
of centres reported having an upper age cut-off (in a similar study of transplanting 
centres)29, and acknowledges the notion that age must not be used as a proxy for 
the assessment of individual need and suitability. It also highlights how clinicians are 
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aware that chronological age can be very different to biological age in different 
individuals, and how assessment needs to be tailored on a case-by-case basis to 
avoid unwarranted age discrimination.  
In contrast to age, the majority of centres used BMI as an exclusion criterion, similar 
to findings from studies from the US30, Canada31 and Europe32, with a wide upper 
BMI limit of 30-40. In the context of an increasingly obese population, such a broad 
range has the potential to cause variation in access to transplantation.  Obese 
patients are certainly at an increased risk of technical difficulties and peri-operative 
complications33-34 though evidence in favour of imposing a BMI limit on the basis of 
more hard end-points (patient and graft survival) is conflicting35-40. A number of 
reports from nationwide databases, including the USA, Australia and the 
Netherlands35, 38, 40, have shown decreased patient and graft survival in obese 
recipients, whilst others showed no differences in survival between obese and non-
obese transplant recipients39. It is unclear in studies where an increase in risk was 
noted, how much would be mitigated once co-existing cardiovascular disease was 
accounted for. This raises the notion that if technically feasible, and cardiovascular 
disease has been ruled out, most patients should be considered for transplantation 
irrespective of their BMI. 
As cardiovascular disease remains the main cause of death in transplant 
recipients41, it is unsurprising that most centres invest a great deal of time and 
resource in its investigation and management. This study showed that most centres 
stratify patients on their level of risk, though the choice of ensuing investigation 
varied greatly with no clear consensus irrespective of risk, from non-invasive 
functional tests to invasive angiography. This variation is likely due to a combination 
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of factors including lack of evidence on superiority for any one investigation, as well 
as local cardiac service availability and experience. Centres also differed in their 
perception of risk associated with angiography in low-clearance patients. Overall this 
variation has the potential for creating inequity, as centres adopting more intense 
screening protocols might impede wait-listing for patients with barriers to getting the 
tests completed. 
Another important issue which needs mentioning is the cost implications of changing 
practice patterns, particularly at a time of receding budgets and rising concern over 
the cost and value of healthcare. Indeed, it is likely that individual centre practices 
are in part, a consequence of local infrastructure and availability of service providers, 
and though instigating some changes may be relatively inexpensive e.g. introducing 
a written protocol, others e.g. introducing universal invasive cardiac screening for 
coronary artery disease, may require significant expenditure. Acknowledging this, 
prior to recommending significant changes to centre practices, it is pertinent to 
demonstrate the medical efficacy and cost-effectiveness of any proposed changes 
on access to transplantation which will also assist in ensuring they are long-lasting. 
Limitations 
Although this study received a 100% response rate across all parts of the UK and 
though the survey instrument was piloted and refined to enhance relevance, 
understandability, and usability; some limitations need to be acknowledged. The 
survey responses were self-reported by self-selecting renal staff e.g. the clinical lead 
for transplantation, and their responses will not necessarily reflect those of the 
broader consultant community. Likewise, as only a small proportion (2.8%) of 
respondents identified themselves as being a transplant surgeon this may have 
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potentially biased the results due to the under-representation of surgical opinion 
amongst responders. Equally, we could not check the validity of responses garnered 
and some of these data were necessarily estimates and so should be regarded with 
caution. There may also have been a social desirability bias in the responses as 
respondents may have answered questions to put their centre in a good light. 
Furthermore, most questions in the survey were multiple-choice questions that 
invited respondents to select the best possible answer out of the choices available. 
This approach necessarily limits their responses, although an option to select "other" 
was provided and the survey was designed following detailed qualitative interviews 
with patients and staff to identify core domains.  
In conclusion there is wide variation in UK practice patterns in listing patients for 
renal transplantation. Potential causes for this are likely to include variation in 
international guidelines and a lack of consensus in evaluating patients especially 
assessing their cardiovascular risk10-14, 28. Differing local population co-morbidity and 
socioeconomic factors may also be playing a role alongside varying physician 
attitudes and beliefs towards transplant listing and risk assessment42. Future 
research should be directed at developing a national consensus on recipient work up 
and in understanding the utility of cardiovascular screening in potential transplant 
recipients, as well as gaining better long-term outcome data on the impact of obesity 
and age on transplantation. 
There is also a need to understand the impact, if any, of this variation on access to 
transplantation. In the UK, as part of the NIHR funded ATTOM study, patient 
variables and the impact of centre variables described in this study, will be further 
evaluated in a multilevel hierarchical model, in a prospective sample of incident 
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dialysis patients recruited as part of the ATTOM Study. 
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Table 1: Reasons for considering raised BMI as a contraindication for 
transplantation by centres adopting a maximum exclusion criterion 
 
    Transplanting Centre Non-Transplanting Centre Overall Nationally 
    N % (of Centres) N  % (of Centres) N % (of Centres) 
Increased post-operative 
complication risk 
16 88.9 34 85 50 86.2 
Increased technical 
difficulty in performing 
procedure 
14 77.8 30 75 44 75.9 
Increased cardiovascular 
risk 
6 33.3 21 52.5 27 46.6 
Lower Graft survival 
compared to a normal BMI 
6 33.3 9 22.5 15 25.9 
Lower patient survival 
compared to normal BMI 
6 33.3 9 22.5 15 25.9 
Other (please specify) 2 11.1 10 25 12 20.7 
Total   50   113   163   
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Table 2: First-line investigation of choice for the assessment of coronary artery 
disease in high-risk patients 
 
    Transplanting Centre 
Non-Transplanting 
Centre Overall Nationally 
    N % (of Centres) N  % (of Centres) N 
% (of 
Centres) 
Exercise Tolerance Test 
5 
21.7 
1
0 
20.8 
1
5 
21.1 
Thallium Stress Test 
7 
30.4 
1
7 
35.4 
2
4 
33.8 
Stress Echocardiography 2 8.7 7 14.6 9 12.7 
Dobutamine Stress Tc 
Scan 
3 
13.0 
6 12.5 9 12.7 
Coronary Angiography 1 4.3 2 4.2 3 4.2 
CPEX Testing* 1 4.3 2 4.2 3 4.2 
Other (please specify) 4 17.4 4 8.3 8 11.3 
*Cardio-Pulmonary Exercise Test 
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Table 3: Continued surveillance of cardiac disease in asymptomatic patients on the 
waiting list reported across UK renal centres 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Transplanting Centre 
Non-Transplanting 
Centre Overall Nationally 
    N % N  % N % 
No routine surveillance if 
asymptomatic 
6 26.1 13 27.1 19 26.8 
All patients screened 
irrespective of remaining 
asymptomatic 
4 17.4 16 33.3 20 28.2 
Surveillance only in high risk 
groups 
12 52.2 11 22.9 23 32.4 
Varies, no specific policy 1 4.3 8 16.7 9 12.7 
Other (please specify) 0 0.0 0 0.0 0 0.0 
Total   23 100.0 48 100.0 71 100.0 
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Figure Legends: 
Figure 1: Bar chart showing proportion of UK Centres performing each investigation 
as part of their routine assessment of patients under consideration for renal 
transplantation wait listing at UK renal centres. 
 
Figure 2: Bar chart showing distribution across renal units of responses to the 
question: “Please indicate your views on whether the following factors 
influence the decision to list a patient” Please indicate how strongly each would 
influence a decision. Values are expressed as percentage of units (n=71). 
 
Figure 3: Bar chart showing distribution across renal units of responses to the 
question: “What is your opinion on the following statements about whether they 
would improve listing of patients for transplantation?” Please indicate how 
strongly you agree or disagree with each of the following.” Values are expressed as 
percentage of units (n=70).  
 
Figure 4: Bar chart showing distribution across renal units of responses to the 
question: “What is your opinion on whether more funding for the following 
resources would improve overall listing and time to listing in your unit? Please 
indicate how strongly you agree or disagree with each of the following.” Values are 
expressed as percentage of units (n=70).  
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Figure 1 Click here to download Figure Figure 1_For Transplantation.jpg 
Figure 2 Click here to download Figure Figure 2_For Transplantation.jpg 
Figure 3 Click here to download Figure Figure 3_For Transplantation.jpg 
Figure 4 Click here to download Figure Figure 4_For Transplantation .jpg 
Transplant Units 
Thank you for completing this survey
This questionnaire  asks about the transplant listing process in your unit. 
Some of the questions address practice patterns that may vary among staff members in your unit. 
Please try to give the answer that is most representative of the unit as a whole (i.e. the whole renal 
service including satellite units).
In order to complete this questionnaire, you may want to consult other members of the renal team 
or to delegate this task to a more appropriate person who has responsibility for such patients (e.g. 
you will be asked who participates in the decision-making process; how the decision is taken). The 
questionnaire will take about 45 minutes to fill in. 
Instructions for completing the questionnaire
 − Please answer each question by ticking the appropriate box(es).
 − The survey can be completed by multiple respondents.  
 − Please return the survey in the FREEPOST envelope provided.
We would be very grateful if you could complete the survey as soon as possible.
  
Prof Paul Roderick, Professor of Public Health, University of Southampton 
Dr Rommel Ravanan, Consultant Nephrologist, Southmead Hospital, Bristol 
Dr Gabriel Oniscu, Consultant Transplant Surgeon, Royal Infirmary of Edinburgh, Edinburgh 
Dr Rishi Pruthi, ATTOM Clinical Research Fellow, UK Renal Registry, Bristol
If you have any queries regarding this questionnaire, please contact: 
Dr Sarah Tonkin-Crine on 023 8024 1080, S.K.Tonkin-Crine@soton.ac.uk
ATTOM Survey
ID
A national survey of practice patterns in UK renal units in listing 
patients for renal transplantation
Additional File For Information Only - not published or cited in text
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Before asking questions regarding your CKD service workforce and organisation in your unit, we 
would like to know the name of your unit and your occupation.
In order to supplement the data publicly available from the UK Renal Registry, please answer the 
following questions. 
1 Please state your role within the renal unit:
Please tick one
Clinical Director Consultant Transplant Surgeon
Consultant Nephrologist 
(other than Clinical Director)
Transplant Co-ordinator
Other  (Please specify) 
 
2 Please enter the name of your renal unit:
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1. Understanding your CKD Service 
Workforce and Organisation
3 For each of the staff roles listed, please provide the number of Whole Time Equivalent (WTE) 
in your centre (e.g. Full-time=1.0 WTE, Half-time=0.5 WTE, Three Full-time staff = 3.0 WTE).  
Put 0 if you do not have any staff in a particular role or leave blank if you do not know the answer.
Please combine contributions across directorates if not all under one single directorate.
Consultant Nephrologists
 
Consultant Transplant Surgeons 
 
Transplant Staff grade/Associate specialist  
 
Nephrology Staff grade/Associate specialist 
 
Transplant recipient Co-ordinators
 
Living kidney Donor Nurses
 
4 How many neighbouring hospitals do you provide a service to? 
Enter number for all that apply
For managing patients with chronic kidney disease  
For transplantation 
5 Which statement best describes how pre-dialysis patients are managed in your unit? 
All pre-dialysis patients are seen in dedicated low clearance clinics
Some pre-dialysis patients are seen in a low clearance clinic whilst some are seen as part of a  
general nephrology clinic
All pre-dialysis patients are seen in a mixed general nephrology clinic alongside other CKD  
patients as there are no specific low clearance clinics (go to question 14)
6 What are the entry criteria for being referred to your low clearance clinic? 
Tick and complete all that apply
eGFR (Please specify)
 
No defined criteria
Expected/projected time frame before 
needing to commence renal replacement 
therapy (Please specify in months)
Other criteria (Please specify)
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7 Who primarily leads the delivery of your low clearance service?
(If jointly led, tick all that apply)
Consultant Nephrologist Nurse
Staff Grade nephrologist
8 In how many of the neighbouring hospitals that you serve for chronic kidney disease do you 
have a dedicated low clearance clinic? 
(Please enter number)
   
9 Which statement most accurately describes your LCC service? 
‘Single Hub and Spokes’: CKD clinics present at all neighbouring hospitals feed into a single main LCC 
clinic based at Main renal unit/hospital 
LCC clinics present at >50% of neighbouring hospitals served by unit 
LCC clinics present at <50% of neighbouring hospitals served by unit
10 Are all pre-dialysis patients referred to a LCC clinic? 
Yes (go to question 13) 
No
11 If No, please explain why a pre dialysis patient might not be referred to a low clearance 
clinic?  
Tick all that apply
Consultant responsible wishes to maintain continuity 
To avoid longer travel times for patient 
Patient choice
Consultant’s belief it would not add any additional value
Patient’s belief it would not add any additional value
Other
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12 If you do not have a Low Clearance Clinic what are the reasons for this?  
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2 Discussing Transplantation  
13 Is transplantation discussed with all pre dialysis patients under 75 years?
Yes (go to question 15)
No
14 If transplantation is not discussed with all patients, please explain how this decision is most 
commonly made: 
Consultant nephrologist decides alone
Consultant nephrologist decides in discussion with other consultants
Consultant nephrologist decides with input from other professionals from an MDT meeting
Clinical nurse specialist/consultant nurse decides alone
Clinical nurse specialist/consultant nurse decides with input from other consultants
Clinical nurse specialist/consultant nurse decides with input from other professionals from an MDT 
meeting
Other (Please specify) 
15 When is transplantation most commonly first discussed with a patient? 
When they are referred to the low clearance clinic
When their eGFR reaches a certain level  
(Please specify)                                                                 
At a specific time point prior to the anticipated start of dialysis 
(Please specify in months)                                                                                            
When symptoms start
After being established on dialysis 
Other (Please specify) 
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16 Who plays the lead/main role in the discussion of transplantation with a patient? 
Consultant Nephrologist
Consultant Surgeon 
Transplant Co-ordinator
Nurse (Pre Dialysis Nurse/Low clearance Nurse/Education Nurse)
Other (Please specify) 
17 Which of the following applies to how education about transplantation is delivered across 
the hospitals you serve? 
Tick all that apply
One to One consultation
DVD education material to take home
Written material to take home
Translated (if appropriate) written material to take home
Computer-based education programme
Group session with other pre-dialysis patients discussing all options of RRT
Group session with other patients considering transplantation discussing just transplantation
Talk from a patient with a functioning transplant
Talk from a patient with failed transplant
Cultural/language matched nurse educators
Home visit education
Education session (based only at main unit)
Education session (based at local hospital)
Other (Please specify) 
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3  Understanding Transplant listing processes 
18 Which type of clinic do patients undergoing transplant work up have their medical 
assessment e.g. tissue typing, cardiac work up?
In their usual general nephrology clinic  (go to question 24)
In a Low Clearance clinic  (go to question 24)
In Clinic run by nephrologist with interest in transplantation  (go to question 24)
In a specific transplant assessment clinic (go to question 19)
Other (if none of the above accurately describe your unit’s organisation please briefly describe here) 
(go to question 24) 
19 How frequently does the transplant assessment clinic take place?
More than once weekly Weekly
Fortnightly Monthly
Less than monthly Other (Please specify) 
20 At which point is a patient referred to the transplant unit?
Before undergoing any  investigations
After completing some baseline investigations
After completing all necessary investigations
Other (Please specify) 
21 Who is involved in the transplant assessment clinics?
Tick all that apply
Usual named consultant nephrologist Local Associate specialist/staff grade
Transplant surgeon Transplant nephrologist
Other (Please specify) 
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22 Do any of the following allied health professionals attend transplant assessment clinics?
Tick all that apply
Education Nurse Transplant Co-ordinator
Living Donor Nurse Other (Please specify) 
23 Which statement best describes the purpose of the transplant assessment clinic:
To assess medical suitability prior to referring patient for surgical review (go to question 24)
To assess medical and surgical suitability prior to referring patient for surgical review  
(go to question 27)
Other (if none of the above are suitable, please specify)
        
Surgical Review
24 Are all patients seen by a transplant surgeon prior to being listed for transplantation?
Yes (skip to question 26) No
25 If no, are all patients discussed with a transplant surgeon prior to being listed for 
transplantation?
Yes No
26 Which statement best describes the timing of surgical involvement/referral?
Patients are referred for surgical assessment as soon as they agree to undergo assessment prior to 
completing any investigations
Patients are referred for surgical assessment after completing their medical assessment
Patients are referred for surgical assessment whilst medical assessment is on-going 
Medical and surgical assessment occurs concurrently at the same clinic appointment
None of the above (Please specify) 
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4 The Assessment Process
27 Please identify the lead/key healthcare professional(s) responsible for performing each 
of the following processes:
Tick all that apply for each
Consultant 
Nephrologist
Transplant 
Surgeon
Staff 
Grade
Transplant 
Co-ordinator
Pre-dialysis 
nurse
Other
Identifies patient for assessment
Refers patient for assessment
Requests investigations for assessment
Follows up investigation results
Organises additional reviews (if required)
Requests Surgical Review
Makes decision to activate patient onto list
Requests NHSBT to activate patient
In charge of overseeing entire process
28 Does your unit have a written transplant work up protocol used for assessment? 
If yes, please could you return this in the stamped addressed envelope with this survey or 
email it to Rishi.Pruthi@nbt.nhs.uk
Yes No
29 Which of the following investigations are performed as part of routine assessment?
For all patients
Only for specific 
indications
Chest x ray
Pelvic X Ray
ECG
Hep B antigen
Hep C antibodies
CMV Serology
EBV
HIV
PSA
Herpes Zoster antibody 
Tissue typing
Lung Function Tests
Upper GI Endoscopy
Sigmoidoscopy/Barium enema
Page 
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For all patients
Only for specific 
indications
CPEX Testing
Echo
ETT
Stress Echo
Thallium Stress Test
Coronary angiogram
Peripheral Doppler
Pelvic Doppler
Voiding Cystourethrogram
Abdo USS
Abdo CT
Other (Please specify)
30 Does your unit have an upper age limit for listing for transplantation?
Yes (Please specify the upper age limit)
    
No
31 Amongst your prevalent CKD 5 and dialysis population which of the following age bands 
corresponds to the level at which you would not expect to see more than 5% listed?
60-64 70-75
65-69 >75
BMI
32 Does your unit have a BMI exclusion criterion for listing?
Yes (Please specify minimum and maximum criteria)
Minimum
                                                    
Maximum
   
No (go to question 35)
Page 
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33 Why does your unit consider a raised BMI a contraindication for transplantation?
Tick all that apply
Increased cardiovascular risk
Lower Graft survival compared to a normal BMI
Lower Graft survival compared to a normal BMI
Increased technical difficulty in performing procedure
Increased post-operative complication risk
Other (Please specify) 
34 If obesity is deemed to rule a patient out for transplantation, which of the following actions 
are routinely employed to facilitate weight loss and subsequent listing of a patient?
Tick all that apply
Verbal motivation in clinic 
Provide written weight loss education
Conservative ‘wait and see’ approach
Refer to dietician
Refer to physiotherapists/physical activity specialist 
Refer to specific weight loss clinic/services 
Refer to other specialists e.g endocrinologists 
Prescribe anti-obesity drugs 
Refer to surgeon specialized in bariatric surgery 
Other (Please specify) 
Cardiac investigations
35 Does your unit stratify patients to guide cardiac investigations?
Yes No (go to question 37)
Page 
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36 If Yes which factors are taken into account when stratifying risk 
Age (Please specify )
     
years
Known history of Diabetes
BMI (Please specify )
   
Smoking history
BP (Hypertension/hypotension)
Abnormal ECG
Previous CVD 
Significant family history
Other (Please specify) 
37 What is the minimum cardiac work-up undertaken? 
Tick all that apply
ECG ECHO
Exercise tolerance test Thallium Stress Test
Stress Echocardiography Dobutamine Stress Tc Scan
Coronary Angiography CPEX Testing
Other (Please specify) 
38 What is your first line investigation for assessing possible underlying coronary artery 
disease in high risk patients if you risk stratify, or any patient if you do not risk stratify? 
Exercise Tolerance test Thallium Stress Test
Stress Echocardiography Dobutamine Stress Tc Scan
Coronary Angiography CPEX Testing
Other (Please specify) 
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39 Who primarily decides which cardiac investigations are required for a moderate to high risk 
patient before listing?
Please tick one
Consultant Nephrologist  
Consultant Transplant Surgeon
Consultant Cardiologist  
Consultant Anaesthetist 
MDT approach 
Other (Please specify) 
40 What are the indications for performing coronary angiography at your unit?
Tick all that apply.  (Note: these are not mutually exclusive) 
All symptomatic patients  
Prior CVD  
Patients with a positive stress test
All diabetics  
Asymptomatic patients with risk factors 
Asymptomatic older patients (Please specify age)
   
No specific policy
Other (Please specify) 
41 If a coronary angiogram is deemed necessary for listing in a low clearance patient, would 
your unit refrain from performing the test until they were on dialysis to avoid precipitating 
the need for dialysis?
Always Sometimes
Never
Page 
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42 Logistics of cardiac investigations
If cardiac investigations are required where are they performed and what are the 
approximate median waiting times in weeks 
Test Local acute  
hospital
Non-transplant 
renal unit hospital
Transplant renal 
unit hospital
Waiting time
ECHO
Exercise Tolerance 
Test
Thallium Stress  
Test
Stress 
Echocardiography
Dobutamine Stress 
Tc Scan
Coronary 
Angiography
CPEX Testing
Other 
(Please state)
43 Does your unit have a named cardiologist to provide advice/review patients undergoing 
assessment for suitability for transplantation?
Yes No (go to question 45)
44 Where are they based and what are the approximate waiting times for review? 
Median waiting time (in weeks)
      
Local acute hospital                                   
      
Non-transplant renal unit hospital
   
Transplant renal unit hospital           
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45 If cardiology investigations and/or a cardiology opinion have been performed by a referring 
non-transplanting unit are these ever repeated at your transplanting unit?
Often Sometimes
Rarely Never (go to question 47)
46 If you selected often/sometimes/rarely please describe why this tends to occur.
 
Peripheral vascular disease assessment
47 In the evaluation of lower limb peripheral vascular disease, peripheral doppler studies are 
obtained on which of the following?  
Note: these are not mutually exclusive
Asymptomatic older patients
All diabetics
Symptomatic patients
Asymptomatic patients with poor peripheral pulses 
Patients with asymptomatic bruit
History of smoking
Other (Please specify) 
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Malignancies
48 Does your unit routinely screen for malignancies as part of transplant assessment work up?
Yes No (go to question 50)
49 Which of the following malignancies are routinely screened for?
Prostate Bladder
Breast Cervical
Skin Colorectal
Other (Please specify) 
Urological evaluation
50 Which statement best describes the urological service available to your unit in assessing 
patients for transplantation?  
Designated urologist with interest in transplantation available on site within urology department
In House trained urologist available as part of surgical transplant team
No designated urologist with an interest in transplantation available 
Other  (Please specify urological support)
Psychological assessment
51 Do most patients undergoing assessment for transplant suitability undergo formal 
psychological assessment?
Yes No (go to question 53)
52  If yes, could you briefly describe what psychological assessment they undergo: 
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53 Do most patients undergoing assessment for transplant suitability undergo formal 
cognitive assessment?
Yes No
54 What psychological support is available at your unit?   
Tick all that apply
Renal Counsellor 
Renal Psychologist
Psychologist/Counsellor shared with other specialities
Other (Please specify) 
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5 Decision Making Process to list patient  
55 How is the final decision to list a patient for transplantation most commonly reached?
By usual named consultant nephrologist  
By Consultant nephrologist at Transplant unit  
Jointly by usual Consultant nephrologist and Consultant Transplant surgeon
Jointly by Consultant nephrologist (at transplanting unit) and Consultant Transplant Surgeon 
By Consultant Transplant Surgeon 
At MDT meeting at transplanting unit
Other (Please specify)
 
56 How is the final decision to list a patient for transplantation, whose CKD/dialysis care is 
under a non-transplant renal unit, most commonly reached?
By usual named consultant nephrologist  
By Consultant nephrologist at Transplant unit  
Jointly by usual Consultant nephrologist and Consultant Transplant surgeon
Jointly by Consultant nephrologist (at transplanting unit) and Consultant Transplant Surgeon 
By Consultant Transplant Surgeon 
At local MDT at non-transplanting unit (without representation present from transplanting unit) 
At local MDT at non-transplanting unit (with representation present from transplanting unit) 
At MDT meeting at transplanting unit (without representation present from non-transplanting unit) 
At MDT meeting at transplanting unit (with representation present from non-transplanting unit)
Other (Please specify)
 
57 Do you utilise an MDT approach in listing patients for transplantation?
Yes No (go to question 61)
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58 If yes, what purpose does it serve?  
Tick all that apply
To discuss ALL patients prior to them being listed 
To discuss complex/borderline patients prior to deciding whether to list or not
Other (Please specify) 
59 How frequently is your MDT held? 
(Please specify ) every
     
weeks
60 Who attends your MDT (either in person or via teleconference/video link up)? 
Consultant nephrologist from non-transplanting unit  
Consultant nephrologist from transplant unit  
Consultant surgeon
Transplant co-ordinator from non-transplanting unit 
Transplant co-ordinator from transplanting unit 
Living Kidney Donor Nurse from non-transplanting unit 
Living Kidney Donor Nurse from transplanting unit 
Other (Please specify)
        
61 Please indicate your views on whether the following factors influence the decision to list a 
patient
Please indicate how strongly you agree or disagree with each of the following
Not at all Very Strongly
Being employed  
High patient enthusiasm 
towards transplantation  
High level of  education  
English as first language  
Having a potential living donor  
Having a potential pre-emptive 
living donor  
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62 If a patient is not suitable for deceased donor transplantation but has a potential living 
donor, would you consider transplantation with a living donor acceptable?
Yes No
63 What proportion of CKD stage 5 patients and dialysis patients under age 75 are informed of 
the decision to list or not? 
All Most
Some Few
None  
64 Do you routinely record all decisions made on the suitability of a patient for transplantation 
on their electronic patient record?
Yes No (go to question 67)
65 If yes, do you audit this?
Yes No (go to question 67)
66 If yes, how frequently do your audit this? 
(Please specify ) every
     
months
67 How long on average does the overall assessment process take from beginning transplant 
work up to being listed in your unit? 
(Please give median answer in months)
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6 Post Assessment/Re-evaluation on the 
waiting list
68 Do you have a unit protocol for the monitoring of patients activated on the transplant list? 
If yes, please could you return this in the stamped addressed envelope with this survey or 
email it to Rishi.Pruthi@nbt.nhs.uk
Yes No
69 Once activated on the transplant list how frequently are patients usually monitored for 
continued suitability?
Never 3 Monthly
6 Monthly Annually
Other (Please specify) 
70 Who reviews/monitors the continued suitability of patients activated on the list?    
Usual dialysis nephrologist at a routine follow up appointment 
Transplant nephrologist in a transplant assessment review clinic
Transplant surgeon in a transplant assessment review clinic
Both nephrologist and transplant surgeon in a transplant assessment review clinic
Other (Please specify) 
71 Do you have a specific transplant review clinic for listed patients? 
Yes No (go to question 83)
72 If yes, how frequently are patients seen in this review clinic? 
6 months  
Annually  
Every two years
Other (Please specify in months)
   
N/A
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73 Which of the following investigations are routinely performed when patients are reviewed? 
Tick all that apply
HIV & Hepatitis Serology PSA
DRE Pelvic examination
Pap smear Breast examination
Mammography Colonoscopy/sigmoidoscopy
Cognitive assessment None of the above
74 Which of the following cardiac investigations (if any) are repeated?   
ECG ECHO
Exercise tolerance test Thallium Stress Test
Stress Echocardiography Dobutamine Stress Tc Scan
Coronary Angiography CPEX Testing
Other (Please specify) 
75 How often are these cardiac investigations repeated?
Provide answers in months
ECG 
 
ECHO 
 
Exercise tolerance test
 
Thallium Stress Test 
 
Stress Echocardiography
 
Dobutamine Stress Tc Scan
 
Coronary Angiography
 
CPEX Testing
 
Other (Please state)
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76 Which of the following accurately describes your local practice in continued surveillance of 
cardiac disease in asymptomatic patients on the waiting list?    
No routine surveillance if asymptomatic 
All patients screened irrespective of remaining asymptomatic
Surveillance only in high risk groups  
Variable , no specific policy
Other (Please specify) 
77 Is psychological support offered routinely to patients listed?  
Yes (go to question 79) No
78 If No, what is the main reason for this?    
Not perceived to be an area where patients require support 
Lack of resources/overburdened counselling service
Do not think that patients’ would make use of this service if offered   
Other (Please specify) 
79 How are patients deemed unsuitable for transplantation in their current state, but with the 
potential to be listed in the future (depending on changing circumstances/factors)  
re-assessed?    
At routine outpatient appointment with regular nephrologist 
At a follow up transplant assessment clinic appointment
At a MDT   
Other (Please specify) 
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7 Working relationships, attitudes and other 
allied health professionals & services 
involved in transplant listing
80 How would you describe your relationship with your local non-transplanting units?
Excellent Very Good
Good Fair
Poor
81 What is your view of the following statements regarding your unit’s interaction with local 
non-transplanting units?  
Please indicate how strongly you agree or disagree with each of the following
Strongly  
agree Agree
Neither agree 
nor disagree Disagree
Strongly 
disagree
Little communication exists with non-
transplanting units  
Non-Transplanting units always refer 
patients with complete investigations  
Non-Transplanting units adhere to 
agreed work up protocol  
Non- transplanting units do not 
have access to adequate cardiology 
investigations/opinions
 
82 Which statement best describes the attitude of your unit staff towards pre-emptive 
transplant listing?    
Everyone has a positive attitude towards listing patients pre-emptively with no exceptions  
The majority of individuals have a positive attitude towards pre-emptive listing
The unit is split roughly 50 50 
The majority have  a negative attitude towards pre-emptive transplantation 
Everyone has a negative attitude towards pre-emptive transplantation 
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83 What is your opinion on the following statements as to the reason behind why certain 
individuals may have a negative attitude towards pre-emptive listing?  
Please indicate how strongly you agree or disagree with each of the following
Strongly  
agree Agree
Neither agree 
nor disagree Disagree
Strongly 
disagree
There is limited evidence that listing 
patients pre-emptively is more beneficial 
as compared to listing after  starting 
dialysis 
 
There is strong evidence to support 
pre-emptive listing, though there is a 
lack of appreciation of this evidence 
amongst those who are less keen to list 
pre-emptively
 
The experience of dialysis before 
transplantation is better for patients as 
it improves their post-transplantation 
adherence and patients value their 
transplant more
 
It is unfair to allocate an organ to a 
patient who has not been on dialysis 
when there are many on the waiting list 
who have been waiting for many years. 
 
84 What is your opinion on the following statements regarding living donation within your 
unit?   
Please indicate how strongly you agree or disagree with each of the following
Strongly  
agree Agree
Neither agree 
nor disagree Disagree
Strongly 
disagree
The work up required to assess suitability 
of living donors for kidney donation is 
well defined 
 
Living donor work up commences 
only once potential recipient has been 
assessed as being suitable and activated 
on the transplant list
 
Potential donors can self-refer for 
assessment  
Potential donors need to be referred by a 
health professional  
Transplant opportunities have been 
delayed/missed due to failure to identify 
existing potential donor early in process 
 
Donation from young female donors 
often poses moral dilemmas for health 
professionals involved in transplantation 
 
High cost of living donation work up is a 
hindrance to working up multiple donors 
simultaneously 
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85 What level of administrative support is provided to the living donor nurse/transplant co-
ordinator?
Nil Designated specific secretary
Shared secretary Other   (Please specify) 
 
86 Do you have an on-site tissue typing service?  
Yes No
87 How long does it usually take for tissue typing to process final samples and request NHSBT 
to activate a patient once decision taken to list?   
(Please specify number of weeks)
   
88 Has processing of tissue typing samples ever been the source of significant delays in listing 
patient for transplantation?  
Yes No
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8 Improving transplant listing 
89 Does your unit undertake any regular audit of whether CKD 5 patients and or those on 
dialysis have been listed?
Yes, 1 to 2 per year Yes, 3 to 4 per year
Yes, 5 or more per year No
Other (Please specify) 
 
90 Has there been any significant improvement in the time taken to complete the overall 
assessment process in your unit over the last year?  
Yes No (go to question 92)
91  If yes, please describe briefly what improvement there has been and how it was achieved. 
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92 What is your opinion on whether more funding for the following resources would improve 
overall listing and time to listing in your unit?    
Please indicate how strongly you agree or disagree with each of the following
Strongly  
agree Agree
Neither agree 
nor disagree Disagree
Strongly 
disagree
Cardiac service  
Tissue typing service  
Education service  
Transplant co-ordinators  
Living donor nurses  
Urology service within transplantation  
Consultant nephrologists with interest in 
transplantation   
Consultant surgeons   
Interpreter service and developing 
pathways to improve language barriers 
amongst ethnic minorities  
 
Administrative support for allied health 
professionals e.g. transplant 
co-ordinators, living donor nurses  
 
Better renal IT systems   
Psychological assessment and 
counselling service   
Increasing operation time slots for 
transplantation service   
Other (Please specify and rate)
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93 What is your opinion on the following statements about whether they would improve listing 
of patients for transplantation?   
Please indicate how strongly you agree or disagree with each of the following
Strongly  
agree Agree
Neither agree 
nor disagree Disagree
Strongly 
disagree
National consensus on cardiac work up  
National consensus on entire work up 
(not just cardiac)  
Improvements in commissioning of 
transplant work up  
Ensuring MDT approach utilised 
systematically in making all decisions to 
list patients or not 
 
Introducing time target for tissue typing 
processing  
Better evidence base behind necessary 
assessment work up  
Further comments on transplant listing
94 If you would like to make any further comments on listing for transplantation, please use 
the space below:
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9 Details of person completing the 
questionnaire
95 If someone else helped you complete this questionnaire, please give their role in renal unit.
 
96 Please provide your contact details in case we need to contact you. This information is 
confidential and will not be used in any research reports. 
Name   
Your role in the renal unit     
Email    
Tel            
                    
If you previously indicated that your unit has a written transplant work up protocol and/or a protocol 
for monitoring patients on the transplant list please could you post these back with this survey.
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